Evidence map›Paper›PMID 25817260›Full record

ArticleThe FEBS journal2015

The C-terminal peptide plays a role in the formation of an intermediate form during the transition between xanthine dehydrogenase and xanthine oxidase.

Tomoko Nishino, Ken Okamoto, Yuko Kawaguchi, Tomohiro Matsumura, Bryan T Eger, Emil F Pai, Takeshi Nishino

Open access · bronzeAbstract read
In one paragraph

Article in The FEBS journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. XDH and XO Research and Drug Discovery-Personal History.Molecules (Basel, Switzerland) · 2023
    Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. NADSignal transduction and targeted therapy · 2020
    Review
  13. Pro-Aging Effects of Xanthine Oxidoreductase Products.Antioxidants (Basel, Switzerland) · 2020
    Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Molybdenum-containing nitrite reductases: Spectroscopic characterization and redox mechanism.Redox report : communications in free radical research · 2017
    Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Tomoko NishinoDepartment of Biochemistry and Molecular Biology, Nippon Medical School, Tokyo, Japan.
Ken OkamotoDepartment of Biochemistry and Molecular Biology, Nippon Medical School, Tokyo, Japan.
Yuko KawaguchiDepartment of Biochemistry and Molecular Biology, Nippon Medical School, Tokyo, Japan.
Tomohiro MatsumuraDepartment of Biochemistry and Molecular Biology, Nippon Medical School, Tokyo, Japan.
Bryan T EgerDepartment of Biochemistry, University of Toronto, ON, Canada.
Emil F PaiDepartment of Biochemistry, University of Toronto, ON, Canada.
Takeshi NishinoDepartment of Biochemistry and Molecular Biology, Nippon Medical School, Tokyo, Japan.
Nippon Medical School · JPUniversity of Toronto · CA

Funding

Canadian Institutes of Health Research MOP-64392
6 · The paper itself

Abstract

unlabelledMammalian xanthine oxidoreductase can exist in both dehydrogenase and oxidase forms. Conversion between the two is implicated in such diverse processes as lactation, anti-bacterial activity, reperfusion injury and a growing number of diseases. We have constructed a variant of the rat liver enzyme that lacks the carboxy-terminal amino acids 1316-1331; it appears to assume an intermediate form, exhibiting a mixture of dehydrogenase and oxidase activities. The purified variant protein retained ~ 50-70% of oxidase activity even after prolonged dithiothreitol treatment, supporting a previous prediction that the C-terminal region plays a role in the dehydrogenase to oxidase conversion. In the crystal structure of the protein variant, most of the enzyme stays in an oxidase conformation. After 15 min of incubation with a high concentration of NADH, however, the corresponding X-ray structures showed a dehydrogenase-type conformation. On the other hand, disulfide formation between Cys535 and Cys992, which can clearly be seen in the electron density map of the crystal structure of the variant after removal of dithiothreitol, goes in parallel with the complete conversion to oxidase, resulting in structural changes identical to those observed upon proteolytic cleavage of the linker peptide. These results indicate that the dehydrogenase-oxidase transformation occurs rather readily and the insertion of the C-terminal peptide into the active site cavity of its subunit stabilizes the dehydrogenase form. We propose that the intermediate form can be generated (e.g. in endothelial cells) upon interaction of the C-terminal peptide portion of the enzyme with other proteins or the cell membrane. DATABASE: Coordinate sets and structure factors for the four crystal structures reported in the present study have been deposited in the Protein Data Bank under the identification numbers 4YRW, 4YTZ, 4YSW, and 4YTY.

Indexed as

Amino Acid SequenceAmino Acid SubstitutionAnimalsCrystallography, X-RayCysteineDithiothreitolGuanidineLiverModels, BiologicalModels, MolecularMolecular Sequence DataMutagenesis, Site-DirectedNADProtein ConformationRatsRecombinant ProteinsCysteineDithiothreitolGuanidineNADRecombinant ProteinsSulfhydryl ReagentsXanthine DehydrogenaseXanthine Oxidaseendothelial cell damagereactive oxygen speciesxanthine dehydrogenasexanthine oxidasexanthine oxidoreductase

Identifiers

PMID25817260
PMCPMC4832347
OpenAlexW1996655431

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.